Market Place
Sourcing Support
All News #Library
Biotech
Genialis Supermodel Predicts Her2 Therapy Response In Patients
13 Apr 2026 //
PHARMIWEB
Tempus Announces Collab with Gilead to Advance Oncology R&D
09 Apr 2026 //
BUSINESSWIRE
Tempus, NYU Langone Health Partner To Advance Precision Oncology
12 Jan 2026 //
BUSINESSWIRE
Tempus To Present Six Abstracts at Society For Immunotherapy
05 Nov 2025 //
BUSINESSWIRE
Tempus, Whitehawk Partner on Biomarker-Based Cancer Research
16 Oct 2025 //
BUSINESSWIRE
Tempus AI in line for $200M from AstraZeneca cancer model deal
23 Apr 2025 //
FIERCE BIOTECH
Tempus & IFLI To Develop Targeted Follicular Lymphoma Therapies
13 Feb 2025 //
BUSINESSWIRE
Tempus Launches Clinical Immune Profile Score Algorithmic Test
07 Nov 2024 //
BUSINESSWIRE
Tempus Expands Takeda Collaboration In Oncology Research
26 Sep 2024 //
BUSINESSWIRE
Tempus Releases New Data at AACR
08 Apr 2024 //
BUSINESSWIRE
Tempus Announces Companion Diagnostic Collaboration with TScan Therapeutics
06 Jul 2023 //
BUSINESSWIRE
Tempus Announces Prospective Study for Biomarker Discovery in SCLC
05 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.